9 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34508957 | Enhanced chemo-photodynamic therapy of an enzyme-responsive prodrug in bladder cancer patient-derived xenograft models. | 2021 Oct | 1 |
2 | 33455274 | Tracking the Footprints of Paclitaxel Delivery and Mechanistic Action via SERS Trajectory in Glioblastoma Cells. | 2020 Sep 14 | 5 |
3 | 31484396 | PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism. | 2019 Sep 3 | 1 |
4 | 29123088 | A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer. | 2017 Nov 9 | 4 |
5 | 25956854 | Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy. | 2015 Aug | 4 |
6 | 24847940 | Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells. | 2014 Jun 2 | 1 |
7 | 22410114 | Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity. | 2012 Jun 28 | 2 |
8 | 17722272 | Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate. | 2006 | 1 |
9 | 9873732 | Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin. | 1998 Dec 1 | 2 |